# Novo Holdings

> Novo Holdings is the investment and holding company of the Novo Nordisk Foundation. Its life-science platform invests from venture formation through growth and principal investments. Novo co-led AnaCardio's €62.5 million Series B.

## Profile

- **Stage-based planning range:** $1M–$10M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** Hellerup, Denmark
- **AUM:** N/A
- **Rounds they lead:** Series A, Series B, Series C, Growth
- **Rounds they invest:** Seed, Series A, Series B, Series B+, Series C, Growth
- **Last verified:** 2026-10-04

## Links

- [Website](https://novoholdings.com/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 4, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/novo-holdings